missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ADAMTSL5 (aa 370-452) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (83%), Rat (83%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-60604 (PA5-60604. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
ADAMTSL5 belongs to a large superfamily containing 20 ADAMTS proteases and at least eight ADAMTS-like proteins. ADAMTS proteases are secreted enzymes with a conserved organization that includes a metalloprotease domain and an ancillary domain containing one or more thrombospondin type 1 repeats (TSR). The ADAMTS-like subfamily comprises proteins homologous to the ADAMTS ancillary domains but lacking the protease domain and hence lacking catalytic activity. The exact role of ADAMTSL5 is currently unknown, but other ADAMTS-like proteins appear to have regulatory roles in the extracellular matrix.
Specifications
Specifications
| Accession Number | Q6ZMM2 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 339366 |
| Name | Human ADAMTSL5 (aa 370-452) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2010109H09Rik; a disintegrin and metalloproteinase; ADAM; ADAMs; ADAMTS like 5; ADAMTSL5; ADAMTSL-5; ADAMTS-like 5; ADAMTS-like protein 5; metalloendopeptidases; Thrombospondin type-1 domain-containing protein 6; thrombospondin, type I domain containing 6; thrombospondin, type I, domain containing 6; THSD6 |
| Common Name | ADAMTSL5 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction